NCM
ABBV icon

Northstar Capital Management’s AbbVie ABBV Stock Holding History

Northstar Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$8K Buy
+100
New +$6.86K 0.01% 81
2018
Q4 		– Sell
-200
Closed -$19K – 77
2018
Q3 		$19K Buy
+200
New +$19K 0.02% 72

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northstar Capital Management's ABBV Position: Q3 2019 in Review

Northstar Capital Management opened a new position in AbbVie (ABBV) in Q3 2019: 100 shares worth $8K. The stake represents 0.01% of the portfolio and ranks #81 among its holdings. This is a return to the name: Northstar Capital Management previously reported a position in ABBV as recently as Q3 2018.

Northstar Capital Management first reported a position in ABBV in Q3 2018 and has held it in 2 quarters since. The position peaked at $19K in Q3 2018. 2,003 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

  • Northstar Capital Management held 100 shares of AbbVie worth $8K as of Q3 2019.
  • AbbVie was a new Northstar Capital Management position in Q3 2019.
  • AbbVie made up 0.01% of Northstar Capital Management's portfolio in Q3 2019, its #81 holding.
  • Northstar Capital Management first reported a position in AbbVie in Q3 2018 and has held it in 2 quarters since.
  • Northstar Capital Management's AbbVie position peaked at $19K in Q3 2018.
  • 2,003 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on Northstar Capital Management's 13F filing for Q3 2019, filed 7 Nov 2019.